Axogen Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $10.5400
- Today's High:
- $11.2600
- Open Price:
- $11.0900
- 52W Low:
- $6.87
- 52W High:
- $14.59
- Prev. Close:
- $11.1700
- Volume:
- 163118
Company Statistics
- Market Cap.:
- $0.450 billion
- Book Value:
- 2.413
- Revenue TTM:
- $0.128 billion
- Operating Margin TTM:
- -24.4%
- Gross Profit TTM:
- $0.104 billion
- Gross Profit TTM:
- $0.104 billion
- Profit Margin:
- -24.7%
- Return on Assets TTM:
- -9.62%
- Return on Equity TTM:
- -28.7%
Company Profile
Axogen Inc had its IPO on 1990-03-27 under the ticker symbol AXGN.
The company operates in the LIFE SCIENCES sector and ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry. Axogen Inc has a staff strength of 0 employees.
Stock update
Shares of Axogen Inc opened at $11.09 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $10.54 - $11.26, and closed at $10.65.
This is a -4.66% slip from the previous day's closing price.
A total volume of 163,118 shares were traded at the close of the day’s session.
In the last one week, shares of Axogen Inc have slipped by -3.18%.
Axogen Inc's Key Ratios
Axogen Inc has a market cap of $0.450 billion, indicating a price to book ratio of 4.64 and a price to sales ratio of 3.513.
In the last 12-months Axogen Inc’s revenue was $0.128 billion with a gross profit of $0.104 billion and an EBITDA of $-0.028 billion. The EBITDA ratio measures Axogen Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Axogen Inc’s operating margin was -24.4% while its return on assets stood at -9.62% with a return of equity of -28.7%.
In Q2, Axogen Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 2.6%.
Axogen Inc’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.766 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Axogen Inc’s profitability.
Axogen Inc stock is trading at a EV to sales ratio of 3.756 and a EV to EBITDA ratio of -18.52. Its price to sales ratio in the trailing 12-months stood at 3.513.
Axogen Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Axogen Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Axogen Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Axogen Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Axogen Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Axogen Inc paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $10.65
- 52-Week High
- $14.59
- 52-Week Low
- $6.87
- Analyst Target Price
- $19.17
Axogen Inc stock is currently trading at $10.65 per share. It touched a 52-week high of $14.59 and a 52-week low of $14.59. Analysts tracking the stock have a 12-month average target price of $19.17.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Axogen Inc
Similar Industry Stocks (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS)
Most Active
Top Gainers
Top Losers
About
AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.